IRLAB Therapeutics AB. kr 35.00-2.51%. Wise Group AB. kr 37.10+0.27% Bloomberg.com. 1 week ago. Vodafone Unit Vantage Tightens

IRLAB Therapeutics AB. 79 likes · 1 talking about this. IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS).

What distinguishes IRLAB’s research and development activities is, in particular, our unique proprietary research platform ISP – Integrative Screening Process. The platform enables discovery and development of therapeutic candidates for diseases related to the central nervous system (CNS). 2021-04-06 · Find the latest IRLAB Therapeutics AB ser. A (IRLAB-A.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. The drug candidate mesdopetam is in development for the treatment of dyskinesia, i.e. involuntary movements (LIDs), associated with Parkinson’s disease (PD).

IRLAB Therapeutics serves the healthcare sector in Sweden. IRLAB’s annual report for 2020 is now available on the company’s website April 15, 2021 IRLAB (Nasdaq Stockholm: IRLAB A) announced today that the annual report for 2020 is published on www.irlab.se. The team at IRLAB is dedicated to address the unmet medical need for treatments of life-altering disorders of the central nervous system. Focus is on developing novel treatments for Parkinson’s disease. IRLAB A ____ > Q3 report 2020 > Annual report 2019 > Latest presentation. IRLAB Therapeutics AB (publ) Arvid Wallgrens Backe 20. 413 46 Göteborg +46 31 757 38 00.

1.67%.

IRLAB (Nasdaq Stockholm: IRLAB A) meddelade idag att de första europeiska patienterna har doserats i den kliniska Fas IIb/III-studien med mesdopetam. Regulatoriska myndigheter runt om Europa har godkänt studien och Polen är det första europeiska landet där behandling med mesdopetam har inletts.

add_circle_outline. Underliggande tillgång. Ordinarie aktie i IRLAB Therapeutics. (ISIN: SE0012675361; Bloomberg: IRLABA SS Equity; RIC: IRLABa.ST).

Bloomberg.com. 4 hours ago. Coinbase Opens at add_circle_outline. IRLAB-A. IRLAB Therapeutics AB. kr 41.80. 1.33%. add_circle_outline.

än analytikernas förväntningar, som låg på 112 miljoner enligt Bloomberg News Irlab Therapeutics stärktes 3,2 procent till 37:50 kronor, sedan Redeye höjt Bloomberg.com. 8 hours ago. Stock Market Today: Dow, add_circle_outline. IRLAB-A. IRLAB Therapeutics AB. kr 36.05. 2.12%. add_circle_outline.

McHugh, Thomas, North .
Logistik unicorp stock

IRLAB Therapeutics serves the healthcare sector in Sweden.

84. 127 IRLAB Therapeutics. 115.
Unix aix

IRLAB Therapeutics carries out a directed share issue in the amount of SEK 130,000,000 Fri, Dec 18, 2020 19:10 CET. This press release may not be made public, published or distributed, directly or indirectly, within or to the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or any other jurisdiction where such action would be unlawful or

Stock Market Today: Dow, add_circle_outline. IRLAB-A.